ABSTRACT
OBJECTIVE: To explore the value of magnetic resonance imaging (MRI) and clinical features in identifying ovarian thecoma-fibroma (OTF) with cystic degeneration and ovary adenofibroma (OAF). METHODS: A total of 40 patients with OTF (OTF group) and 28 patients with OAF (OAF group) were included in this retrospective study. Univariable and multivariable analyses were performed on clinical features and MRI between the two groups, and the receiver operating characteristic (ROC) curve was plotted to estimate the optimal threshold and predictive performance. RESULTS: The OTF group had smaller cyst degeneration degree (P < .001), fewer black sponge sign (20% vs. 53.6%, P = .004), lower minimum apparent diffusion coefficient value (ADCmin) (0.986 (0.152) vs. 1.255 (0.370), P < .001), higher age (57.4 ± 14.2 vs. 44.1 ± 15.9, P = .001) and more postmenopausal women (72.5% vs. 28.6%, P < .001) than OAF. The area under the curve of MRI, clinical features and MRI combined with clinical features was 0.870, 0.841, and 0.954, respectively, and MRI combined with clinical features was significantly higher than the other two (P < .05). CONCLUSION: The cyst degeneration degree, black sponge sign, ADCmin, age and menopause were independent factors in identifying OTF with cystic degeneration and OAF. The combination of MRI and clinical features has a good effect on the identification of the two. ADVANCES IN KNOWLEDGE: This is the first time to distinguish OTF with cystic degeneration from OAF by combining MRI and clinical features. It shows the diagnostic performance of MRI, clinical features, and combination of the two. This will facilitate the discriminability and awareness of these two diseases among radiologists and gynaecologists.
Subject(s)
Adenofibroma , Magnetic Resonance Imaging , Ovarian Neoplasms , Thecoma , Humans , Female , Middle Aged , Retrospective Studies , Diagnosis, Differential , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/pathology , Magnetic Resonance Imaging/methods , Thecoma/diagnostic imaging , Thecoma/pathology , Adult , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Fibroma/diagnostic imaging , Aged , Ovarian Cysts/diagnostic imagingABSTRACT
PURPOSE: Biliary adenofibroma is a solid microcystic epithelial neoplasm in the liver, comprising microcystic and tubuloacinar glandular tissues lined by a non-mucin secreting biliary epithelium and supported by a fibrous stroma. It is an extremely rare benign tumor with potential for malignant transformation. Herein, we report the case of a 64-year-old woman diagnosed with intrahepatic cholangiocarcinoma arising from biliary adenofibroma. METHODS: Imaging studies revealed a tumor of 50 mm diameter, consisting of two components in S1 of the liver. The ventral portion of the tumor showed an ill-defined mass with early peripheral and gradual centripetal enhancement invading to the middle hepatic vein on computed tomography (CT), diffusion restriction on magnetic resonance images, and high fluorine-18-2-deoxy-D-glucose (FDG) uptake on positron emission tomography, like conventional intrahepatic cholangiocarcinoma. The dorsal portion showed a well-defined and low-attenuated mass with heterogeneous early enhancement and partial wash-out on CT, marked hyperintensity on heavily T2-weighted images, and low FDG uptake. The patient subsequently underwent extended left hepatectomy. RESULTS: Pathologically, the former was diagnosed as cholangiocarcinoma and the latter as biliary adenofibroma. We discuss the radiological-pathological correlation of the tumor with a literature review. CONCLUSION: Preoperative diagnosis of biliary adenofibroma is extremely challenging; however, clinically, it is crucial not to miss the presence of malignant findings.
Subject(s)
Adenofibroma , Bile Duct Neoplasms , Cholangiocarcinoma , Gastrointestinal Neoplasms , Female , Humans , Middle Aged , Fluorodeoxyglucose F18 , Bile Duct Neoplasms/diagnostic imaging , Bile Duct Neoplasms/surgery , Cholangiocarcinoma/diagnostic imaging , Cholangiocarcinoma/surgery , Cholangiocarcinoma/pathology , Gastrointestinal Neoplasms/pathology , Multimodal Imaging , Bile Ducts, Intrahepatic/diagnostic imaging , Bile Ducts, Intrahepatic/pathology , Adenofibroma/diagnostic imaging , Adenofibroma/surgeryABSTRACT
Adenofibroma is an extremely rare benign biphasic tumour composed of glandular and fibrous tissues. It occurs more often in the endometrium but it can also occur in the cervix and extrauterine sites. This case report describes a 39-year-old asymptomatic woman with cervical adenofibroma. The patient was treated successfully with surgical removal of the tumour. As adenofibromas are very rare, the report is presented with a brief review of the literature.
Subject(s)
Adenofibroma , Uterine Cervical Neoplasms , Adenofibroma/diagnostic imaging , Adenofibroma/surgery , Adult , Female , Humans , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/surgeryABSTRACT
BACKGROUND: Biliary adenofibroma (BAF) is a rare primary hepatic tumor with the potential risk of malignant transformation. Given the extreme rarity of the disease, the imaging features of BAF are unclear. We presented a case of malignant BAF and conducted a systematic literature review. We highlighted the key imaging features in the diagnosis and aggressiveness assessment of BAF, as well as the role of various imaging modalities in evaluating BAF. CASE PRESENTATION: We reported a 64-year-old woman with a 5-months history of pain in the right upper quadrant abdomen. US of the liver showed a hypoechoic subcapsular nodule. CT scan revealed a subcapsular solid-cystic mass in segment V of the liver. The mass showed a marked enhancement in the arterial phase followed by wash-out in the venous phase. The patient underwent partial resection of liver's right lobe. The mass was diagnosed as BAF with malignant transformation by postoperative pathology. CONCLUSIONS: CT and MRI are helpful in recognizing and characterizing BAF. The imaging features of BAF include a solitary, large solid-cystic mass with a well-defined margin, lobulated shape, and internal septa; subcapsular location; no intrahepatic bile duct communication; the presence of von Meyenberg complexes in background liver. The enhancement patterns may have the potential to assess the aggressiveness of BAF, and that marked enhancement in the arterial phase followed by wash-out in the venous phase is suggestive of malignant BAF.
Subject(s)
Adenofibroma , Gastrointestinal Neoplasms , Liver Neoplasms , Abdomen , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Adenofibroma/surgery , Female , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/surgery , Middle Aged , Tomography, X-Ray ComputedABSTRACT
Pulmonary adenofibroma is a rare biphasic tumor that contains epithelial and stromal components. We report a case of pulmonary adenofibroma in which the tumor was resected by thoracoscopic surgery and the diagnosis was established by histopathology. A 59-year-old woman with a past medical history of pyelonephritis visited our hospital for evaluation of an abnormal opacity on a plain chest x-ray during a comprehensive medical examination. A follow-up chest x-ray showed enlargement of the lesion, and the patient was referred to our department for further management. Chest computed tomography revealed a well-circumscribed nodule measuring 1.4 cm in diameter in the upper lobe of the left lung. The chest imaging findings suggested a benign tumor, but because of evidence of lesion enlargement and elevated serum carcinoembryonic antigen levels, we performed wide wedge resection of the left upper lobe by video-assisted thoracoscopic surgery, for diagnosis and treatment. The resected specimen was submitted for rapid pathological diagnosis during the operation, and a benign tumor, possibly sclerosing pneumocytoma, was suspected. Therefore, we completed the operation with wide wedge resection. The final histopathological diagnosis was pulmonary adenofibroma. The patient had an uneventful postoperative course, and at this writing, 6 months postoperatively, there has been no evidence of tumor recurrence. We have reported this case of pulmonary adenofibroma because the tumor is rare, has not yet been well-characterized, and has an unclear prognosis. Collection of data from a larger number of patients is necessary.
Subject(s)
Adenofibroma/surgery , Lung Neoplasms/surgery , Thoracic Surgery, Video-Assisted/methods , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Female , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Middle Aged , Neoplasm Recurrence, Local , Pulmonary Sclerosing Hemangioma , Treatment OutcomeABSTRACT
BACKGROUND: Adenofibroma is a benign tumor composed histologically of epithelial elements and mesenchymal stroma. Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma. Carcinosarcoma arising from adenofibroma of the uterus has never been reported in the literature in English language. Case Presentaion: We report a case of a 56-year-old woman who complained vaginal spotting persisting for several months. We described here for the first time a case of malignant transformation of uterine endometrial adenofibroma into carcinosarcoma that was depicted as a multilocular cystic lesion with enhancing solid portions and stalk-like structure between the myometrium and endometrial mass.
Subject(s)
Adenofibroma , Carcinosarcoma , Adenofibroma/diagnostic imaging , Carcinosarcoma/diagnostic imaging , Female , Humans , Middle Aged , Myometrium , Uterine HemorrhageABSTRACT
Biliary adenofibroma is a rare tumor with a bile duct origin characterized by a complex tubulocystic non-mucin secreting biliary epithelium with abundant fibrous stroma. The MRI features of biliary adenofibroma are not well established. The authors encountered two patients with biliary adenofibroma and reviewed the literature focusing on the MRI findings. A well-circumscribed multicystic tumor with septal enhancement and no intrahepatic bile duct communication may be the characteristic MRI findings of biliary adenofibroma.
Subject(s)
Adenofibroma/diagnosis , Bile Duct Neoplasms/diagnosis , Magnetic Resonance Imaging , Adenofibroma/complications , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Adult , Bile Duct Neoplasms/complications , Bile Duct Neoplasms/diagnostic imaging , Bile Duct Neoplasms/pathology , Hepatitis B, Chronic/complications , Hepatitis B, Chronic/diagnosis , Humans , Male , Middle Aged , Tomography, X-Ray ComputedABSTRACT
Mucinous neoplasms of the ovary account for 10%-15% of ovarian neoplasms. They may be benign, borderline, or malignant. The large majority are benign or borderline, accounting for 80% and 16%-17%, respectively. Mucinous neoplasms of the ovary most commonly affect women in their 20s to 40s. The clinical manifestation is nonspecific, but most mucinous ovarian neoplasms manifest as large unilateral pelvic masses. At gross pathologic analysis, mucinous ovarian neoplasms appear as large multiloculated cystic masses. The contents of the cyst loculi vary on the basis of differences in internal mucin content. At histologic analysis, mucinous ovarian neoplasms are composed of multiple cysts lined by mucinous epithelium, often resembling gastrointestinal-type epithelium. Imaging evaluation most commonly includes US and/or MRI. The imaging findings parallel the gross pathologic features and include a large, unilateral, multiloculated cystic mass. The cyst loculi vary in echogenicity, attenuation, and signal intensity depending on the mucin content. Mucinous neoplasms of the ovary are staged surgically using the FIGO (International Federation of Gynecology and Obstetrics) staging system. Primary treatment is surgical, with adjuvant chemotherapy considered in the uncommon case of mucinous carcinoma with extraovarian disease. Since most mucinous ovarian neoplasms are benign or borderline, the overall prognosis is excellent.
Subject(s)
Adenocarcinoma, Mucinous/diagnostic imaging , Cystadenoma, Mucinous/diagnostic imaging , Ovarian Neoplasms/diagnostic imaging , Tomography, X-Ray Computed/methods , Ultrasonography/methods , Adenocarcinoma, Mucinous/epidemiology , Adenocarcinoma, Mucinous/pathology , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Adult , Aged , Appendiceal Neoplasms/diagnostic imaging , Brenner Tumor/diagnostic imaging , Brenner Tumor/pathology , Cystadenoma, Mucinous/epidemiology , Cystadenoma, Mucinous/pathology , Diagnosis, Differential , Epithelium/pathology , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Neoplasm Staging , Ovarian Cysts/diagnostic imaging , Ovarian Cysts/pathology , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/pathology , Positron Emission Tomography Computed Tomography , Tumor Burden , Young AdultABSTRACT
Pulmonary adenofibroma (PAF) is a rare neoplasm that may be related to solitary fibrous tumor (SFT). A subset of PAFs harbor the NAB2-STAT6 fusion that is typical of SFT, but a significant proportion do not. Their distinction is clinically important as SFTs can potentially have an aggressive clinical course, while there has been no report of a PAF behaving in a malignant fashion. We report a case of a 60-year-old male who developed a SFT and PAF in the same lung. The SFT harbored a NAB2-STAT6 fusion, while the PAF did not have any identifiable fusion. This case represents the first instance of a single patient with both of these tumors occurring simultaneously in the same lung.
Subject(s)
Adenofibroma/pathology , Lung Neoplasms/pathology , Neoplasms, Multiple Primary/pathology , Solitary Fibrous Tumors/pathology , Adenofibroma/diagnostic imaging , Adenofibroma/genetics , Adenofibroma/surgery , Biomarkers, Tumor/genetics , Humans , Lung/diagnostic imaging , Lung/pathology , Lung/surgery , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/genetics , Lung Neoplasms/surgery , Male , Middle Aged , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/genetics , Neoplasms, Multiple Primary/surgery , Oncogene Proteins, Fusion/genetics , Pneumonectomy , Repressor Proteins/genetics , STAT6 Transcription Factor/genetics , Solitary Fibrous Tumors/diagnostic imaging , Solitary Fibrous Tumors/genetics , Solitary Fibrous Tumors/surgery , Tomography, X-Ray ComputedABSTRACT
The Bi-RADS (Breast Imaging Reporting and Data System) classification developed by the ACR (American College of Radiology) is the classification system for radiological images recommended for breast cancer screening. The ACR 4 microcalcification is an indeterminate or suspected abnormality with 2-95% probability of malignancy, according to studies. This disparity pushed us to conduct this retrospective study of 181 patients in the Department of Obstetrics and Gynecology I at the Hassan II University Hospital, Fez, over a period of 5 years. This study aimed to report the histological results of breast lesions radiologically classified as ACR4 in order to assess their radio-histological correlation and to improve therapeutic approach. All patients underwent breast imaging examinations and then anatomopathologic examination was performed using different techniques. There was a clear predominance of benign lesions with a rate of 62% versus 29% of malignant lesions and only 9% were intermediate lesions. Adenofibroma was the most common histological finding (30% of cases), invasive ductal carcinoma was the most frequent malignant lesion (17% of cases). We performed a literature review which showed that our results were in line with findings of other studies, with a positive predictive value of 29%. Nevertheless, ACR classification divided into subcategories 4a, b and c should be used due to the significant number of unnecessary surgical interventions.
Subject(s)
Breast Diseases/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Calcinosis/diagnostic imaging , Adenofibroma/diagnostic imaging , Adenofibroma/epidemiology , Adenofibroma/pathology , Adolescent , Adult , Aged , Breast Diseases/epidemiology , Breast Diseases/pathology , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Calcinosis/epidemiology , Calcinosis/pathology , Carcinoma, Intraductal, Noninfiltrating/diagnostic imaging , Carcinoma, Intraductal, Noninfiltrating/epidemiology , Carcinoma, Intraductal, Noninfiltrating/pathology , Female , Hospitals, University , Humans , Mass Screening/methods , Middle Aged , Morocco/epidemiology , Predictive Value of Tests , Retrospective Studies , Young AdultABSTRACT
Ovarian clear cell adenofibroma is uncommon, and borderline clear cell adenofibroma (low malignant potential) is extremely rare. Borderline clear cell adenofibromas may represent the precursor lesion of clear cell adenocarcinoma of the ovary, but this has not been established. We present a case of a woman in her mid-50s with a clear cell adenofibroma ranging from benign to borderline to frankly invasive. While some clear cell adenocarcinomas are thought to arise from endometriosis, this range of findings supports the theory that some ovarian clear cell adenocarcinomas originate from borderline tumors.
Subject(s)
Adenocarcinoma, Clear Cell/pathology , Adenofibroma/pathology , Colon, Sigmoid/pathology , Ovarian Neoplasms/pathology , Sigmoid Neoplasms/pathology , Adenocarcinoma, Clear Cell/complications , Adenocarcinoma, Clear Cell/diagnostic imaging , Adenocarcinoma, Clear Cell/secondary , Adenofibroma/diagnostic imaging , Adenofibroma/surgery , Cell Transformation, Neoplastic , Colectomy , Colon, Sigmoid/diagnostic imaging , Colon, Sigmoid/surgery , Female , Gastrointestinal Hemorrhage/diagnostic imaging , Gastrointestinal Hemorrhage/etiology , Humans , Incidental Findings , Middle Aged , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/surgery , Ovary/cytology , Ovary/diagnostic imaging , Ovary/pathology , Ovary/surgery , Salpingo-oophorectomy , Sigmoid Neoplasms/complications , Sigmoid Neoplasms/diagnostic imaging , Sigmoid Neoplasms/secondary , Tomography, X-Ray ComputedABSTRACT
Uterine cervical adenofibroma, a very rare benign neoplasm, has rarely been reported in imaging features in the English literature. Herein, we describe a case of uterine cervical adenofibroma that was depicted as a multilocular cystic lesion with enhanced solid portions.
Subject(s)
Adenofibroma/diagnostic imaging , Cervix Uteri/diagnostic imaging , Ultrasonography/methods , Uterine Cervical Neoplasms/diagnostic imaging , Adenofibroma/surgery , Cervix Uteri/surgery , Cysts , Diagnosis, Differential , Female , Humans , Hysterectomy , Middle Aged , Uterine Cervical Neoplasms/surgeryABSTRACT
We are reporting one case of multiple pulmonary adenofibromas in a 57-year-old non-smoking female. Ten well-circumscribed masses were identified in both lungs. The masses are characterized by gland-like structures lined by a single layer of simple cuboidal or columnar epithelium. The stroma is abundant and demonstrates compact spindle-cells. The epithelial component is generally positive for CK7, TTF-1, Napsin A. The stromal component displays expression of vimentin, desmin, SMA, h-CALD, ER, PR, Bcl-2, and is negative for CD34, CD117, CD99. We are postulating that the possible histogenesis of these lesions is via proliferation of mesenchymal component of the peribronchial wall, which entraps the epithelium as it expands. Hitherto, this is the first case with multiple lesions reported. Currently, the patient is 11 months post-surgery and doing well.
Subject(s)
Adenofibroma/pathology , Lung Neoplasms/pathology , Adenofibroma/diagnostic imaging , Female , Humans , Immunohistochemistry , Immunophenotyping , Lung Neoplasms/diagnostic imaging , Middle Aged , Radiography, ThoracicABSTRACT
PURPOSE: To retrospectively compare the MR findings of histological subtypes of clear cell carcinomas (CCCs) of the ovary. MATERIALS AND METHODS: This single-center retrospective study was approved by the institutional review board, and the requirement for informed consent was waived. Between April 2005 and August 2015, we found 51 consecutive patients with histopathologically proven CCCs. Among them, 44 CCCs in 37 patients who underwent preoperative MR imaging were included. CCCs were pathologically divided into three subgroups: (1) four clear cell adenofibroma-associated CCCs, (2) 21 endometriosis-associated CCCs, and (3) 19 indeterminate CCCs. The statistical tests were used to compare the frequency of qualitative assessments and value of quantitative measurements among the histological subtypes. RESULTS: On T2-weighted images, hypointense areas within solid components were more frequently observed in clear cell adenofibroma-associated CCCs [3/4 (75%)] than in the remaining CCCs [1/40 (3%)] (p < 0.01), and the signal intensity ratios (SIRs) of solid components were significantly lower in clear cell adenofibroma-associated CCCs (0.27 ± 0.13) than in the remaining CCCs (0.61 ± 0.18) (p < 0.01). On T1-weighted images, hyperintensities of cystic components were more frequently observed in the endometriosis-associated CCCs [17/21 (81%)] than in the remaining CCCs [5/20 (25%)] (p < 0.01), and the SIRs of cystic components were significantly higher in endometriosis-associated CCCs (2.99 ± 1.51) than in the remaining CCCs (1.82 ± 1.10) (p < 0.01). CONCLUSION: MR features may help differentiate between adenofibroma-associated and endometriosis-associated CCC.
Subject(s)
Adenocarcinoma, Clear Cell/diagnostic imaging , Adenocarcinoma, Clear Cell/pathology , Magnetic Resonance Imaging/methods , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/pathology , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Adult , Aged , Contrast Media , Diagnosis, Differential , Endometriosis/diagnostic imaging , Endometriosis/pathology , Female , Gadolinium DTPA , Humans , Middle Aged , Retrospective StudiesABSTRACT
Tamoxifen is a widely used in anti-oestrogen treatment of breast cancer. Previous reports showed that tamoxifen is associated with proliferative endometrial lesions. We herein reported an unusual case of concurrent hyperplastic lesions in the uterine cavity and right ovary in a 45-year-old woman with tamoxifen therapy. Regular vaginal ultrasonography showed the progressive endometrial thickening and right ovary enlargement during the period of drug use. Both lesions in the uterine cavity and right ovary showed characteristics resembling that of Müllerian adenofibroma. There were also foci of endometriosis in her bilateral ovarian surfaces. We suggest that women taking tamoxifen with a known history of endometriosis should be followed with transvaginal ultrasonography periodically.
Subject(s)
Adenofibroma/chemically induced , Antineoplastic Agents, Hormonal/adverse effects , Breast Neoplasms/drug therapy , Carcinoma, Ductal, Breast/drug therapy , Ovarian Neoplasms/chemically induced , Selective Estrogen Receptor Modulators/adverse effects , Tamoxifen/adverse effects , Uterine Neoplasms/chemically induced , Adenofibroma/diagnostic imaging , Adenofibroma/pathology , Adenofibroma/surgery , Biopsy , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/surgery , Chemotherapy, Adjuvant , Female , Humans , Hyperplasia , Hysterectomy , Middle Aged , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Ovariectomy , Salpingectomy , Treatment Outcome , Ultrasonography , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/pathology , Uterine Neoplasms/surgeryABSTRACT
BACKGROUND: Cytology for breast lesions is a safe, rapid and cost-effective with a high specificity and sensitivity. OBJECTIVE: To determine the cytomorphologic patterns of breast lesions identified among a group of Sudanese patients. MATERIALS AND METHODS: This study included 759 patients undergoing either a fine needle aspiration FNA, nipple discharge (ND) smears or breast skin scraping (SS) at a cytology clinic in Khartoum. Clinical and demographic data were reviewed. Stained smears were categorized into: inadequate sample, normal breast, benign lesion, suspicious, or malignant neoplasm. RESULTS: of the 759 cases, 734 (96.71%) were FNA, 18 (2.37%) ND and 7 cases (0.92%) SS. For 28 cases, FNA was done under ultrasound guidance. Females were 720 (94.86%). Benign lesions were 423(55.75%) and 248 (32.67%) were malignant and 77 (10.14%) of smears were normal without any detected abnormality. Ten (1.31%) cases were suspicious for malignancy, and only one case (0.13%) was reported as inadequate. Most lesions were observed among the age group 30 years and above. CONCLUSION: Most patients investigated have benign lesions, one third of cytological smears were malignant. FNAC is a useful tool for investigating breast lesions in limited-resource settings.